Gainers

• GlucoTrack (NASDAQ:GCTK) stock increased by 39.7% to $1.02 during Wednesday's regular session. The company's market cap stands at $2.6 million.
• Avalo Therapeutics (NASDAQ:AVTX) stock rose 31.54% to $21.39. The market value of their outstanding shares is at $370.5 million.
• Pomdoctor (NASDAQ:POM) shares increased by 29.27% to $0.51. The market value of their outstanding shares is at $47.0 million.
• InflaRx (NASDAQ:IFRX) stock rose 28.17% to $2.53. The market value of their outstanding shares is at $142.4 million.
• MannKind (NASDAQ:MNKD) shares rose 24.61% to $3.56. The market value of their outstanding shares is at $869.0 million. As per the news, the Q1 earnings report came out today.
• Veracyte (NASDAQ:VCYT) shares moved upwards by 23.26% to $40.64. The market value of their outstanding shares is at $2.6 billion. The company's, Q1 earnings came out yesterday.

Losers

• Apimeds Pharmaceuticals (AMEX:APUS) stock fell 33.0% to $2.01 during Wednesday's regular session. The company's market cap stands at $37.7 million. The company's, Q4 earnings came out 2 days ago.
• Alphatec Holdings (NASDAQ:ATEC) shares fell 31.14% to $7.04. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q1 earnings came out yesterday.
• Azenta (NASDAQ:AZTA) stock decreased by 25.64% to $18.3. The market value of their outstanding shares is at $1.1 billion. As per the news, the Q2 earnings report came out yesterday.
• TransMedics Group (NASDAQ:TMDX) shares decreased by 23.38% to $72.74. The market value of their outstanding shares is at $3.2 billion. The company's, Q1 earnings came out yesterday.
• Hyperion DeFi (NASDAQ:HYPD) shares decreased by 23.13% to $3.59. The company's market cap stands at $38.1 million.
• EUDA Health Holdings (NASDAQ:EUDA) shares fell 20.24% to $13.01. The market value of their outstanding shares is at $40.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.